Glaucoma

Top Story

FDA accepts application for Bimatoprost Sustained-Release

July 17, 2019

iSTAR's MINIject shows positive 18-month results

July 12, 2019
iSTAR Medical’s MINIject device showed positive results in a first-in-human trial, with a mean pressure reduction of 15 mm Hg at 18 months, according to a press…

New ocular health supplement targets glaucoma

July 10, 2019
Guardion Health Sciences Inc. announced the launch of GlaucoCetin, a propriety formula shown in a clinical trial to reverse mitochondrial dysfunction in the optic nerve…

Netarsudil trial completes enrollment in Japan

July 10, 2019
Aerie Pharmaceuticals has completed enrollment in a phase 2 clinical trial of netarsudil ophthalmic solution in Japan, according to a press release. The prospective…
More Headlines »
CME

ROCK-solid Inhibition in Glaucoma Therapy

This activity is supported by an educational grant from Aerie Pharmaceuticals, Inc.

The medical management of glaucoma is primarily focused on lessening intraocular pressure (IOP) by reducing aqueous…
More »
Video
Meeting News

VIDEO: Bimatoprost SR shows long-term IOP lowering

May 25, 2019
More »
Video
Meeting News

VIDEO: US launch of Rocklatan and other updates from Aerie

July 9, 2019
More »